| Literature DB >> 30970026 |
Andrija Javor1, Julia Ferrari2, Alexandra Posekany3,4, Susanne Asenbaum-Nan1.
Abstract
BACKGROUND AND OBJECTIVES: Differences in stroke risk factors and treatment variables between rural and urban regions in Austria were analyzed retrospectively as European data on this topic are scarce. RESEARCH DESIGN AND METHODS: We performed statistical analysis using group comparisons and time series analysis of data of the Austrian Stroke Unit Registry between 2005 and 2016. 87411 patients were divided into three groups (rural, intermediate, urban) according to the degree of urbanisation classification of the European Commission/Eurostat.Entities:
Mesh:
Year: 2019 PMID: 30970026 PMCID: PMC6457636 DOI: 10.1371/journal.pone.0214980
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Visualization of urban, intermediate and rural areas in Austria.
Analysis of risk factors for stroke.
| Variable | Urban group | Intermediate group | Rural group | Relative difference |
|---|---|---|---|---|
| Arterial hypertension | 21058 (80.5) | 15405 (78.4) | 26904 (78.7) | 2.29 |
| Diabetes | 7158 (27.4) | 4778 (24.3) | 7956 (23.3) | 17.60 |
| Prior strokes | 6780 (25.9) | 4344 (22.1) | 7368 (21.6) | 19.91 |
| Prior heart attacks | 2886 (11) | 1751 (8.9) | 2692 (7.9) | 39.24 |
| Hypercholesterolemia | 15290 (58.4) | 10325 (52.5) | 18098 (52.9) | 10.40 |
| Atrial fibrillation | 6969 (26.6) | 5105 (26) | 9222 (27) | - |
| Other cardiac disease | 5851 (22.4) | 4167 (21.2) | 7646 (22.4) | - |
| Peripheral artery disease | 2132 (8.1) | 1281 (6.5) | 2149 (6.3) | 28.57 |
| Smoking | 6200 (23.7) | 3248 (16.5) | 4869 (14.2) | 66.90 |
| Regular alcohol consumption | 2395 (9.2) | 1398 (7.1) | 2374 (6.9) | 33.33 |
| Acute alcohol intoxication | 131 (0.5) | 104 (0.5) | 162 (0.5) | - |
+ Relative difference: between urban and rural group in %
* Level of significance at least p<0.001
Summary of pre- and post-Stroke disability variables.
| Variable | Urban group | Intermediate group | Rural group | Relative difference |
|---|---|---|---|---|
| mRS before event < = 1 | 21572 (75.6) | 17231 (80.5) | 29797 (80.7) | 6.75 |
| mRS before event > = 2 (N, %) | 6967 (24.4) | 4183 (19.5) | 7117 (19.3) | - |
| NIH SS | 4 (1, 8) | 4 (1, 8) | 4 (1, 8) | 0 |
| mRS < = 1 (N,%) | 8055 (28.2) | 6156 (28.7) | 10570 (28.6) | - |
| mRS> = 2 (N,%) | 20484 (71.8) | 15258 (71.3) | 26344 (71.4) | - |
| NIH SS | 2 (0, 5) | 2 (0, 5) | 2 (0, 5) | 0 |
| mRS < = 1 (N,%) | 11258 (43.6) | 8692 (44.7) | 14631 (43.6) | - |
| mRS> = 2 (N,%) | 14568 (56.4) | 10771 (55.3) | 18918 (56.4) | - |
| Mortality (N,%) | 707 (2.7) | 430 (2.2) | 803 (2.4) | - |
| mRS < = 1 | 5427 (48.5) | 3595 (52.2) | 5519 (51.8) | 6.80 |
| mRS> = 2 (N,%) | 5766 (51.5) | 3288 (47.8) | 5128 (48.2) | - |
+ Relative difference: between urban and rural group in %
* Level of significance at least p<0.001
mRS = modified Rankin scale, NIH SS = National Institutes of Health Stroke Scale
Etiology, treatment and time variables.
| Variable | Urban group | Intermediate group | Rural group | Relative difference |
|---|---|---|---|---|
| Microangiopathy | 7031 (24.5) | 4471 (20.8) | 7935 (21.3) | 15.02 |
| Macroangiopathy | 2577 (9) | 2642 (12.3) | 4190 (11.2) | - |
| Cardioembolic | 6070 (21.2) | 4747 (22.1) | 8771 (23.5) | - |
| Others | 629 (2.2) | 402 (1.9) | 670 (1.8) | - |
| Unkown | 12333 (43.1) | 9243 (43) | 15700 (42.1) | - |
| Thombolysis rate, iv | 3733 (14.3) | 3403 (17.3) | 5314 (15.6) | 9.09 |
| Endovascular treatment (%) | 362 (4.6) | 217 (4) | 366 (3.7) | - |
| Referral rate to rehabilitation | 3725 (38.1) | 2444 (39.9) | 3856 (41.1) | 7.87 |
| ODT | 105 (60, 253) | 118 (60, 260) | 120 (65, 261.2) | 14.29 |
| DNT | 48 (32, 70) | 48 (30,71) | 45 (30, 70) | 6.67 |
| OTT | 120 (92, 165.5) | 123 (90, 170) | 130 (100, 173) | 8.33 |
| Time to first cerebral imaging | 30 (17, 61) | 30 (15, 69) | 30 (15, 60) | 0 |
| Time to first vascular imaging | 240 (60, 1263) | 100 (40, 900) | 105 (40, 940.5) | 128.57 |
+ Relative difference: between urban and rural group in %
* Level of significance at least p<0.001
iv = intravenous, ODT = onset-to-door time, DNT = door-to-needle-time, OTT = onset-to-treatment time
Fig 2Development of Onset-to-door (ODT) times during the observation period of this study.